Dasyam, Nathaniel
Sharples, Katrina J.
Barrow, Catherine
Huang, Ying
Bauer, Evelyn
Mester, Brigitta
Wood, Catherine E.
Authier-Hall, Astrid
Dzhelali, Marina
Ostapowicz, Tess
Kumar, Rajiv
Lowe, Jessica
Maxwell, Alice
Burn, Olivia K.
Williams, Geoffrey M.
Carley, Sarah E.
Caygill, Graham
Jones, Jeremy
Chan, Susanna T. S.
Hinder, Victoria A.
Macapagal, Jerome
McCusker, Monica
Weinkove, Robert
Brimble, Margaret A.
Painter, Gavin F.
Findlay, Michael P.
Dunbar, P. Rod
Gasser, Olivier
Hermans, Ian F.
Funding for this research was provided by:
Health Research Council of New Zealand (10/667, 10/667, 10/667, 10/667, 14/1003, 10/667, 10/667, 10/667, 10/667, 10/667, 10/667, 10/667, 10/667)
Victoria University of Wellington
Article History
Received: 21 February 2022
Accepted: 6 February 2023
First Online: 7 March 2023
Declarations
:
: The Ferrier Research Institute and GlycoSyn are commercial suppliers of clinical grade alpha-galactosylceramide.